| Literature DB >> 23960025 |
Katherine S Yang1, Ghyslain Budin, Carlos Tassa, Olivier Kister, Ralph Weissleder.
Abstract
A proteomics method to pull down secondary drug targets from live cells is described. The drug of interest is modified with trans-cyclooctene (TCO) and incubated with live cells. Upon cell lysis, the modified drug bound to the protein is pulled down using magnetic beads decorated with a cleavable tetrazine-modified linker. Samples are then run on an SDS-PAGE gel and isolated bands are submitted for mass spectrometry analysis to identify drug targets.Entities:
Keywords: bioorthogonal reaction; cleavable linkers; drug targets; proteins; proteomics
Mesh:
Year: 2013 PMID: 23960025 PMCID: PMC3856564 DOI: 10.1002/anie.201304096
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336